Tandem Diabetes Care, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Tandem Diabetes Care, Inc. (TNDM) had Restricted Cash and Cash Equivalents, Noncurrent of $10.00 million as of 2018-06-30, per its 10-Q filed 2018-07-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2019-02-26
- 2018-06-30: Restricted Cash and Cash Equivalents, Noncurrent $10.00M.
- 2018-03-31: Restricted Cash and Cash Equivalents, Noncurrent $10.00M.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $10.00M.
- 2017-09-30: Restricted Cash and Cash Equivalents, Noncurrent $10.00M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2018-06-30 | $10.00M 10-Q · filed 2018-07-30 |
| 2018-03-31 | $10.00M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $10.00M 10-K · filed 2019-02-26 |
| 2017-09-30 | $10.00M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $10.00M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $10.00M 10-Q · filed 2017-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |